NasdaqGM - Delayed Quote • USD
XOMA Corporation (XOMA)
At close: 4:00 PM EDT
After hours: 6:17 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.79 | -0.72 | -2.14 | -1.7 |
| Low Estimate | -0.82 | -0.77 | -2.23 | -1.91 |
| High Estimate | -0.76 | -0.67 | -2.05 | -1.5 |
| Year Ago EPS | -0.98 | -0.59 | -2.66 | -2.14 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 1.7M | 2.46M | 14.1M | 20.65M |
| Low Estimate | 1.31M | 1.72M | 8.3M | 12.2M |
| High Estimate | 2.1M | 3.2M | 19.9M | 29.1M |
| Year Ago Sales | 437k | 1.66M | 4.76M | 14.1M |
| Sales Growth (year/est) | 289.00% | 48.40% | 196.30% | 46.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.52 | -0.48 | -0.36 |
| EPS Actual | -0.98 | -0.59 | -0.6 | -0.49 |
| Difference | -0.48 | -0.07 | -0.12 | -0.13 |
| Surprise % | -96.00% | -13.50% | -25.00% | -36.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.79 | -0.72 | -2.14 | -1.7 |
| 7 Days Ago | -0.79 | -0.72 | -2.14 | -1.7 |
| 30 Days Ago | -0.79 | -0.72 | -2.14 | -1.7 |
| 60 Days Ago | -0.58 | -0.39 | -1.19 | -0.81 |
| 90 Days Ago | -0.58 | -0.39 | -1.19 | -0.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | XOMA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 19.40% | -- | -- | 2.60% |
| Next Qtr. | -22.00% | -- | -- | 13.40% |
| Current Year | 19.50% | -- | -- | 5.20% |
| Next Year | 20.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 19.00% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/25/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/22/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/9/2023 |
Related Tickers
GNFT Genfit S.A.
3.4500
+0.15%
IVA Inventiva S.A.
3.1600
-2.77%
KYMR Kymera Therapeutics, Inc.
33.35
-5.28%
THRD Third Harmonic Bio, Inc.
10.46
-7.68%
CGEM Cullinan Therapeutics, Inc.
19.25
+1.91%
AVTE Aerovate Therapeutics, Inc.
21.57
+1.75%
ASND Ascendis Pharma A/S
136.93
-4.37%
GMAB Genmab A/S
27.46
-3.55%
LIFE aTyr Pharma, Inc.
1.5950
-0.31%
CALT Calliditas Therapeutics AB (publ)
19.45
+0.73%